Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

92 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Optimizing Oral Targeted Anticancer Therapies Study for Patients With Solid Cancer: Protocol for a Randomized Controlled Medication Adherence Program Along With Systematic Collection and Modeling of Pharmacokinetic and Pharmacodynamic Data.
Bandiera C, Cardoso E, Locatelli I, Digklia A, Zaman K, Diciolla A, Cristina V, Stravodimou A, Veronica AL, Dolcan A, Sarivalasis A, Liapi A, Bouchaab H, Orcurto A, Dotta-Celio J, Peters S, Decosterd L, Widmer N, Wagner D, Csajka C, Schneider MP. Bandiera C, et al. Among authors: widmer n. JMIR Res Protoc. 2021 Jun 29;10(6):e30090. doi: 10.2196/30090. JMIR Res Protoc. 2021. PMID: 34185020 Free PMC article.
[Principles of therapeutic drug monitoring].
Widmer N, Csajka C, Werner D, Grouzmann E, Decosterd LA, Eap CB, Biollaz J, Buclin T. Widmer N, et al. Rev Med Suisse. 2008 Jul 16;4(165):1644-8. Rev Med Suisse. 2008. PMID: 18767290 Review. French.
[Therapeutic drug monitoring: clinical practice].
Widmer N, Werner D, Grouzmann E, Eap CB, Marchetti O, Fayet A, Csajka C, Decosterd LA, Buclin T. Widmer N, et al. Rev Med Suisse. 2008 Jul 16;4(165):1649-50, 1652-60. Rev Med Suisse. 2008. PMID: 18767291 French.
Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry.
Haouala A, Zanolari B, Rochat B, Montemurro M, Zaman K, Duchosal MA, Ris HB, Leyvraz S, Widmer N, Decosterd LA. Haouala A, et al. Among authors: widmer n. J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Jul 15;877(22):1982-96. doi: 10.1016/j.jchromb.2009.04.045. Epub 2009 May 13. J Chromatogr B Analyt Technol Biomed Life Sci. 2009. PMID: 19505856
92 results